TScan Therapeutics holds annual meeting; elects three Class I directors and ratifies auditor

TScan Therapeutics, Inc.

Elected Stephen Biggar, Gavin MacBeath, and Garry Nicholson as Class I directors for three-year terms through 2028.
Garry Nicholson received 25.65M votes for and 5.86M withheld; Biggar and MacBeath each received >31M votes for.
Ratified Deloitte & Touche as independent auditor for FY2025 with 45.72M votes for, 64K against, 36K abstain.
Broker non-votes totaled 14.31M on director elections, indicating some institutional abstentions.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.